Order Article Reprints

Bali ZK, Bruszt N, Kőszegi Z, Nagy LV, Atlasz T, Kovács P, Csupor D, Csupor-Löffler B, Hernádi I. Aconitum Alkaloid Songorine Exerts Potent Gamma-Aminobutyric Acid-A Receptor Agonist Action In Vivo and Effectively Decreases Anxiety without Adverse Sedative or Psychomotor Effects in the Rat. Pharmaceutics. 2022; 14(10):2067. https://doi.org/10.3390/pharmaceutics14102067

Bali, Zsolt Kristóf, Nóra Bruszt, Zsombor Kőszegi, Lili Veronika Nagy, Tamás Atlasz, Péter Kovács, Dezső Csupor, Boglárka Csupor-Löffler, and István Hernádi. 2022. "Aconitum Alkaloid Songorine Exerts Potent Gamma-Aminobutyric Acid-A Receptor Agonist Action In Vivo and Effectively Decreases Anxiety without Adverse Sedative or Psychomotor Effects in the Rat" Pharmaceutics 14, no. 10: 2067. https://doi.org/10.3390/pharmaceutics14102067

Bali, Z. K., Bruszt, N., Kőszegi, Z., Nagy, L. V., Atlasz, T., Kovács, P., Csupor, D., Csupor-Löffler, B., & Hernádi, I. (2022). Aconitum Alkaloid Songorine Exerts Potent Gamma-Aminobutyric Acid-A Receptor Agonist Action In Vivo and Effectively Decreases Anxiety without Adverse Sedative or Psychomotor Effects in the Rat. Pharmaceutics, 14(10), 2067. https://doi.org/10.3390/pharmaceutics14102067